“QUAD SHOT” Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
Description
During this study, patients will receive infusions of pembrolizumab with radiotherapy (palliative QUADSHOT regimen). The patient will receive treatment of pembrolizumab once every 3 weeks and palliative “QUAD SHOT” radiotherapy every 4 weeks. These 28 day period of time is called a cycle. The cycle will be repeated 3 times. Each cycle is numbered in order. The patient will be treated for up to 3 cycles followed by pembrolizumab single drug until unacceptable toxicity or tumor progression.
The patient will also complete a survey.
Total duration of the study is up to two years.
Our expert team has 10+ years running successful recruitment campaigns for clinical research sites